• You are here: Home
  • Daclizumab Monoclonal Antibody Drug. Targets CD25 (alpha Subunit Of IL-2 Receptor On T-cells) And Is Used In Treatment Of Multiple
Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple

  • Preview image in your
    Facebook Timeline Account

  • Preview

  • Price: 1$
  • Size Facebook: 1702 x 630 px
  • Size Twitter: 1500 x 500 px
  • Size LinkedIn: 1128 x 191 px

More Facebook, Twitter and LinkedIn Cover Photos

More

Cover photo info

  • Photo title: Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple
  • Author: Molekuul
  • Cover photo description:
  • Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple sclerosis. Generic name and stylized antibody representation
  • Image ID:186826608
  • Views:0
  • Downloads:0

Keywords for Facebook, Twitter and LinkedIn timeline photos

antibody biological biosimilar biotech biotechnology cd25 daclizumab disease drug il2 immunoglobulin immunology infusion injection inn mab monoclonal ms multiple nomenclature peptide protein receptor rejection scleroris tcell transplant

Similar images from Dreamstime

Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
 
  • You are here: Home
  • Daclizumab Monoclonal Antibody Drug. Targets CD25 (alpha Subunit Of IL-2 Receptor On T-cells) And Is Used In Treatment Of Multiple
x